Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials.

By K. Lees, E. Bluhmki, R. von Kummer, T. Brott, D. Toni, J. Grotta, G. Albers, M. Kaste, J. Marler, S. Hamilton and 15 more. The Lancet, 2010

2,150 citations recorded by the source corpus.

Subfields: Epidemiology, Molecular Biology, Neurology

View Paper: https://www.semanticscholar.org/paper/b1d2b83ee5e72a9fa9f4fa8305632bfacbd130b8

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. D. Lackland
2. G. Howard
3. L. Lisabeth
4. Mary G. George
5. M. Fornage
6. S. Kittner
7. J. Lichtman
8. B. Kissela

Citations in the corpus

• Factors Influencing the Decline in Stroke Mortality (2013, background): “68).(332) Additionally, only a small proportion of ischemic stroke patients are treated with tPA.”